SCHEMBL15720899

SCHEMBL15720899

COc1cc(N)cc(OS(C)(=O)=O)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR6 P50406 1/20 0.45
ALDH1A1 P00352 6/20 0.44
CYP19A1 P11511 3/20 0.43
NQO2 P16083 2/20 0.43
CYP3A4 P08684 2/20 0.41
CYP1A1 P04798 2/20 0.40
CYP1B1 Q16678 2/20 0.40
CA1 P00915 1/20 0.39
CA2 P00918 1/20 0.39
CA9 Q16790 1/20 0.39
TDP1 Q9NUW8 2/20 0.37
MAPK1 P28482 1/20 0.37
SMN1; SMN2 Q16637 2/20 0.36
HPGD P15428 1/20 0.36
HSD17B10 Q99714 1/20 0.36
GAA P10253 1/20 0.35
ESR1 P03372 2/20 0.34
ABL1 P00519 1/20 0.34
TTR P02766 1/20 0.34
CYP1A2 P05177 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9957932 0.89 ALDH1A1 (0.55) ALDH1A1CYP19A1NQO2CYP3A4CYP1A1
SCHEMBL9958096 0.89 ALDH1A1 (0.55) ALDH1A1CYP19A1NQO2CYP3A4CYP1A1
SCHEMBL8194919 0.82 ALDH1A1 (0.46) ALDH1A1CYP3A4CYP1A1CYP1B1CA1
SCHEMBL2083820 0.80 ALDH1A1 (0.44) ALDH1A1CYP3A4CYP1A1CYP1B1CA1
SCHEMBL9957670 0.80 ALDH1A1 (0.44) ALDH1A1CYP19A1NQO2CYP1A1CYP1B1
SCHEMBL927493 0.80 ALDH1A1 (0.45) ALDH1A1CA1CA2CA9HPGD
SCHEMBL116606 0.80 ALDH1A1 (0.69) HTR6ALDH1A1CYP19A1NQO2CYP3A4
Ammonia Solution, Strong SCHEMBL10988442 0.78 ALDH1A1 (0.65) HTR6ALDH1A1CYP19A1NQO2CYP3A4
SCHEMBL21611343 0.78 ALDH1A1 (0.65) HTR6ALDH1A1CYP19A1NQO2CYP3A4
Hydrochloric Acid SCHEMBL3275940 0.78 ALDH1A1 (0.65) HTR6ALDH1A1CYP19A1NQO2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9732063-B2 Kinase inhibitors RESPIVERT LIMITED (GB) 2017-08-15 US disclosed
EP-2925742-B1 KINASE INHIBITORS RESPIVERT LTD (GB) 2016-10-26 EP disclosed
US-20150329523-A1 KINASE INHIBITORS OXULAR ACQUISITIONS LIMITED (GB) 2015-11-19 US disclosed
EP-2925742-A1 KINASE INHIBITORS Respivert Limited (GB) 2015-10-07 EP disclosed
WO-2014076484-A1 KINASE INHIBITORS RESPIVERT LIMITED (GB) 2014-05-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150329523-A1 KINASE INHIBITORS SYK, SRC, BTK HTR6 1475/4885ALDH1A1 4202/4885CYP19A1 2071/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.